Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem AG
02 1Dr.Reddy's Laboratories Limited
03 1Ambiopharm, Inc.
04 1Chengdu Shengnuo Biopharm Co. Ltd
05 1Hainan Shuangcheng Pharmaceuticals Co., Ltd.
06 1Hybio Pharmaceutical Co., Ltd. (Pingshan Factory)
07 1Patheon Italia S.p.A
08 1Plantex Ltd
09 1Sandoz Inc
10 1ScinoPharm Taiwan Ltd.
11 1Sinopep-Allsino Biopharmaceutical Co., Ltd.
01 1BIVALIRUDIN
02 6Bivalirudin
03 1Bivalirudin Trifluoroacetate
04 3bivalirudin
01 3China
02 1India
03 1Israel
04 2Switzerland
05 1Taiwan
06 3U.S.A
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 55463-0029
Start Marketing Date : 2012-03-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-918
Start Marketing Date : 2010-03-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41524-0001
Start Marketing Date : 2011-01-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 32861-0001
Start Marketing Date : 2011-12-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52958-112
Start Marketing Date : 2019-10-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14403-0005
Start Marketing Date : 2011-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68225-041
Start Marketing Date : 2000-12-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (250mg/5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 36974-0066
Start Marketing Date : 2017-06-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0781-3453
Start Marketing Date : 2000-12-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (250mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 65129-1225
Start Marketing Date : 2010-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Bivalirudin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bivalirudin, including repackagers and relabelers. The FDA regulates Bivalirudin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bivalirudin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bivalirudin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bivalirudin supplier is an individual or a company that provides Bivalirudin active pharmaceutical ingredient (API) or Bivalirudin finished formulations upon request. The Bivalirudin suppliers may include Bivalirudin API manufacturers, exporters, distributors and traders.
click here to find a list of Bivalirudin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bivalirudin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Bivalirudin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Bivalirudin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Bivalirudin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Bivalirudin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Bivalirudin suppliers with NDC on PharmaCompass.
We have 11 companies offering Bivalirudin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
